Cell cycle regulator in primary lung adenocarcinoma and its haematogenous metastases [8]

Histopathology

Volumn 50, Issue 4, 2007, Pages 525-527

  Saito, D M S ^b   Franco, M R ^a   Parra, E R ^a   Ab'Saber, A M ^a   Farhat, C ^a   Eher, E ^a   Soufen, M A ^b   Rodrigues, R ^b   Capelozzi, V L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; DNA;

ADULT; AGED; CANCER CELL; CANCER GROWTH; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DNA REPAIR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORPHOMETRICS; MULTIVARIATE ANALYSIS OF COVARIANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 33847279833     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02623.x     Document Type: Letter

References (10)

1. Janssen-Heijnen ML, Gatta G, Forman D et al. Variation in survival of patients with lung cancer in Europe. Eur. J. Cancer 1998; 34; 2191-2196.
2. Wingo PA, Ries LA, Rosenberg HM et al. Cancer incidence and mortality, 1973-1995: a report card for the US. Cancer 1998; 82; 1197-1207.
3. Younes RN. Lung cancer: role of surgery in the treatment of non-small cell lung cancer stages I, II and III. S. Am. J. Cancer 1997; 1; 153.
4. Veale D, Kerr N, Gibson GJ et al. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br. J. Cancer 1993; 68; 162-165.
5. Delmonte Capelozzi V, Battlehner CN, Montes GS et al. Volume fraction of dense-core granules correlates well with survival in disseminated (Stage IV) neuroendocrine carcinoma of the lung. Pathol. Prac. Res. 1993; 189; 1145-1148.
6. Antonangelo L, Bernardi FDC, Capelozzi VL et al. Morphometric evaluation of argyrophilic nucleolar organizer region is useful in predicting long-term survival in squamous cell carcinoma of the lung. Chest 1997; 111; 110-114.
7. Gugger M, Kappeler A, Vonlanthen S et al. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer 2001; 33; 229-239.
8. Keum JS, Kong G, Yang SC et al. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br. J. Cancer 1999; 81; 127-132.
9. Folkman J. What is the evidence that tumours are angiogenesis dependent? J. Natl Cancer Inst. 1990; 82; 4-6.
10. Blood CH, Zetter B et al. Tumor interactions with the vasculature: angiogenesis and tumor metastases. Biochem. Byophys. Acta 1990; 1032; 89-118.